Tommaso Mauri1,2, Laura Alban3, Cecilia Turrini3, Barbara Cambiaghi4, Eleonora Carlesso1, Paolo Taccone2, Nicola Bottino2, Alfredo Lissoni2, Savino Spadaro3, Carlo Alberto Volta3, Luciano Gattinoni5, Antonio Pesenti6,7, Giacomo Grasselli2. 1. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. 2. Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milan, Italy. 3. Department of Morphology, Surgery and Experimental Medicine, Section of Anesthesia and Intensive Care, University of Ferrara, Ferrara, Italy. 4. Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy. 5. Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany. 6. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. antonio.pesenti@unimi.it. 7. Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milan, Italy. antonio.pesenti@unimi.it.
Abstract
PURPOSE: Limited data exist on the correlation between higher flow rates of high-flow nasal cannula (HFNC) and its physiologic effects in patients with acute hypoxemic respiratory failure (AHRF). We assessed the effects of HFNC delivered at increasing flow rate on inspiratory effort, work of breathing, minute ventilation, lung volumes, dynamic compliance and oxygenation in AHRF patients. METHODS: A prospective randomized cross-over study was performed in non-intubated patients with patients AHRF and a PaO2/FiO2 (arterial partial pressure of oxygen/fraction of inspired oxygen) ratio of ≤300 mmHg. A standard non-occlusive facial mask and HFNC at different flow rates (30, 45 and 60 l/min) were randomly applied, while maintaining constant FiO2 (20 min/step). At the end of each phase, we measured arterial blood gases, inspiratory effort, based on swings in esophageal pressure (ΔPes) and on the esophageal pressure-time product (PTPPes), and lung volume, by electrical impedance tomography. RESULTS: Seventeen patients with AHRF were enrolled in the study. At increasing flow rate, HFNC reduced ΔPes (p < 0.001) and PTPPes (p < 0.001), while end-expiratory lung volume (ΔEELV), tidal volume to ΔPes ratio (V T/ΔPes, which corresponds to dynamic lung compliance) and oxygenation improved (p < 0.01 for all factors). Higher HFNC flow rate also progressively reduced minute ventilation (p < 0.05) without any change in arterial CO2 tension (p = 0.909). The decrease in ΔPes, PTPPes and minute ventilation at increasing flow rates was better described by exponential fitting, while ΔEELV, V T/ΔPes and oxygenation improved linearly. CONCLUSIONS: In this cohort of patients with AHRF, an increasing HFNC flow rate progressively decreased inspiratory effort and improved lung aeration, dynamic compliance and oxygenation. Most of the effect on inspiratory workload and CO2 clearance was already obtained at the lowest flow rate.
PURPOSE: Limited data exist on the correlation between higher flow rates of high-flow nasal cannula (HFNC) and its physiologic effects in patients with acute hypoxemic respiratory failure (AHRF). We assessed the effects of HFNC delivered at increasing flow rate on inspiratory effort, work of breathing, minute ventilation, lung volumes, dynamic compliance and oxygenation in AHRF patients. METHODS: A prospective randomized cross-over study was performed in non-intubated patients with patients AHRF and a PaO2/FiO2 (arterial partial pressure of oxygen/fraction of inspired oxygen) ratio of ≤300 mmHg. A standard non-occlusive facial mask and HFNC at different flow rates (30, 45 and 60 l/min) were randomly applied, while maintaining constant FiO2 (20 min/step). At the end of each phase, we measured arterial blood gases, inspiratory effort, based on swings in esophageal pressure (ΔPes) and on the esophageal pressure-time product (PTPPes), and lung volume, by electrical impedance tomography. RESULTS: Seventeen patients with AHRF were enrolled in the study. At increasing flow rate, HFNC reduced ΔPes (p < 0.001) and PTPPes (p < 0.001), while end-expiratory lung volume (ΔEELV), tidal volume to ΔPes ratio (V T/ΔPes, which corresponds to dynamic lung compliance) and oxygenation improved (p < 0.01 for all factors). Higher HFNC flow rate also progressively reduced minute ventilation (p < 0.05) without any change in arterial CO2 tension (p = 0.909). The decrease in ΔPes, PTPPes and minute ventilation at increasing flow rates was better described by exponential fitting, while ΔEELV, V T/ΔPes and oxygenation improved linearly. CONCLUSIONS: In this cohort of patients with AHRF, an increasing HFNC flow rate progressively decreased inspiratory effort and improved lung aeration, dynamic compliance and oxygenation. Most of the effect on inspiratory workload and CO2 clearance was already obtained at the lowest flow rate.
Authors: Gonzalo Hernández; Concepción Vaquero; Laura Colinas; Rafael Cuena; Paloma González; Alfonso Canabal; Susana Sanchez; Maria Luisa Rodriguez; Ana Villasclaras; Rafael Fernández Journal: JAMA Date: 2016-10-18 Impact factor: 56.272
Authors: Tommaso Mauri; Cecilia Turrini; Nilde Eronia; Giacomo Grasselli; Carlo Alberto Volta; Giacomo Bellani; Antonio Pesenti Journal: Am J Respir Crit Care Med Date: 2017-05-01 Impact factor: 21.405
Authors: Salvatore Maurizio Maggiore; Francesco Antonio Idone; Rosanna Vaschetto; Rossano Festa; Andrea Cataldo; Federica Antonicelli; Luca Montini; Andrea De Gaetano; Paolo Navalesi; Massimo Antonelli Journal: Am J Respir Crit Care Med Date: 2014-08-01 Impact factor: 21.405
Authors: B Rochwerg; D Granton; D X Wang; Y Helviz; S Einav; J P Frat; A Mekontso-Dessap; A Schreiber; E Azoulay; A Mercat; A Demoule; V Lemiale; A Pesenti; E D Riviello; T Mauri; J Mancebo; L Brochard; K Burns Journal: Intensive Care Med Date: 2019-03-19 Impact factor: 17.440
Authors: Kwang Won Seo; Jong-Joon Ahn; Yangjin Jegal; Seung Won Ra; Soohyun Bae; Jin Hyoung Kim; Byung Ju Kang Journal: Intensive Care Med Date: 2018-01-10 Impact factor: 17.440
Authors: Amanda Corley; Claire M Rickard; Leanne M Aitken; Amy Johnston; Adrian Barnett; John F Fraser; Sharon R Lewis; Andrew F Smith Journal: Cochrane Database Syst Rev Date: 2017-05-30
Authors: Francesca Simioli; Anna Annunziata; Giorgio Emanuele Polistina; Antonietta Coppola; Valentina Di Spirito; Giuseppe Fiorentino Journal: Healthcare (Basel) Date: 2021-05-22
Authors: Domenico Luca Grieco; Salvatore Maurizio Maggiore; Oriol Roca; Elena Spinelli; Bhakti K Patel; Arnaud W Thille; Carmen Sílvia V Barbas; Marina Garcia de Acilu; Salvatore Lucio Cutuli; Filippo Bongiovanni; Marcelo Amato; Jean-Pierre Frat; Tommaso Mauri; John P Kress; Jordi Mancebo; Massimo Antonelli Journal: Intensive Care Med Date: 2021-07-07 Impact factor: 17.440